Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Amphotericin B | Case report

Paraplegia secondary to disseminated mucormycosis: case report and literature review

Authors: Xiangjun Shi, Lei Qi, Boran Du, Xingchen Yao, Xinru Du

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

We report a case of spine infection with mucormycosis that manifested signs of paraplegia in a patient suffering from disseminated mucormycosis. Timely and effective surgery was performed. A review of the literature is included.

Case presentation

A patient with diabetic ketoacidosis complained of back pain and fatigue for one month, and his right lower extremity activity had been limited for 10 days. T4–T6 vertebral and paravertebral soft tissue-involved infections were identified by MRI, which were derived from right lung pneumonia. He underwent abscess debridement, spinal canal decompression, pedicle screw fixation and amphotericin B liposome injection. Histopathological examination revealed broad aseptate hyphae suggestive of invasive mucormycosis. There was improvement in neurological function after surgical and medical treatment. Three months after the surgery, the patient died of uncontrollable massive bleeding of the urinary system. Mucormycosis is characterized by rapid development and a high mortality rate. This case shows the significance of a multidisciplinary team in the diagnosis and treatment of patients with mucormycosis. In addition, orthopedic surgeons should design appropriate surgery plans for spine-involved mucormycosis patients.

Conclusion

This case present a patient with paraplegia caused by the spread of pulmonary mucormycosis to the vertebral and paravertebral soft tissue of levels T4–T6. After medical treatment, surgical debridement and internal fixation, the patient recovered well but later patient died of possible disease dissemination to the renal or urinary tract which resulted in massive haemorrhage.
Literature
1.
go back to reference Camara-Lemarroy CR, Gonzalez-Moreno EI, Rodriguez-Gutierrez R, et al. Clinical features and outcome of mucormycosis. Interdiscip Perspect Infect Dis. 2014;2014:562–610.CrossRef Camara-Lemarroy CR, Gonzalez-Moreno EI, Rodriguez-Gutierrez R, et al. Clinical features and outcome of mucormycosis. Interdiscip Perspect Infect Dis. 2014;2014:562–610.CrossRef
3.
go back to reference Skiada A, Lassfloerl C, Klimko N, et al. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol. 2018;56:93–101.CrossRef Skiada A, Lassfloerl C, Klimko N, et al. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol. 2018;56:93–101.CrossRef
4.
go back to reference Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18:556–69.CrossRef Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18:556–69.CrossRef
5.
go back to reference Giuliani A, Mettimano M, Viviani D, et al. An uncommon case of systemic Mucormycosis associated with spinal cord infarction in a recently diagnosed diabetic. Int J Immunopathol Pharmacol. 2010;23:355–8.CrossRef Giuliani A, Mettimano M, Viviani D, et al. An uncommon case of systemic Mucormycosis associated with spinal cord infarction in a recently diagnosed diabetic. Int J Immunopathol Pharmacol. 2010;23:355–8.CrossRef
6.
go back to reference Petrikkos G, Skiada A, Lortholary O, et al. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23.CrossRef Petrikkos G, Skiada A, Lortholary O, et al. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23.CrossRef
7.
go back to reference Diamond R, Krzesicki R, Epstein B, et al. Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis. Am J Pathol. 1978;91:313–28.PubMedPubMedCentral Diamond R, Krzesicki R, Epstein B, et al. Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis. Am J Pathol. 1978;91:313–28.PubMedPubMedCentral
8.
go back to reference Hadgaonkar S, Shah K, Bhojraj S, et al. Isolated mucormycotic spondylodiscitis of lumbar spine-a rare case report. J Orthop Case Rep. 2015;5:55–7.PubMedPubMedCentral Hadgaonkar S, Shah K, Bhojraj S, et al. Isolated mucormycotic spondylodiscitis of lumbar spine-a rare case report. J Orthop Case Rep. 2015;5:55–7.PubMedPubMedCentral
9.
go back to reference Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53.CrossRef Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53.CrossRef
10.
go back to reference Buruma OJ, Craane H, Kunst MW. Vertebral osteomyelitis and epidural abcess due to mucormycosis, a case report. Clin Neurol Neurosurg. 1979;81:39–44.CrossRef Buruma OJ, Craane H, Kunst MW. Vertebral osteomyelitis and epidural abcess due to mucormycosis, a case report. Clin Neurol Neurosurg. 1979;81:39–44.CrossRef
11.
go back to reference Machida U, Kami M, Uozaki H, et al. Subacute spinal cord infarction due to zygomycotic thrombosis in a patient with myelodysplastic syndrome. Haematologica. 2000;85:1004–6.PubMed Machida U, Kami M, Uozaki H, et al. Subacute spinal cord infarction due to zygomycotic thrombosis in a patient with myelodysplastic syndrome. Haematologica. 2000;85:1004–6.PubMed
12.
go back to reference Chen F, Lü G, Kang Y, et al. Mucormycosis spondylodiscitis after lumbar disc puncture. Eur Spine J. 2006;15:370–6.CrossRef Chen F, Lü G, Kang Y, et al. Mucormycosis spondylodiscitis after lumbar disc puncture. Eur Spine J. 2006;15:370–6.CrossRef
13.
go back to reference Navanukroh O, Jitmuang A, Chayakulkeeree M, et al. Disseminated Cunninghamella bertholletiae infection with spinal epidural abscess in a kidney transplant patient: case report and literature review. Transpl Infect Dis. 2014;16:658–65.CrossRef Navanukroh O, Jitmuang A, Chayakulkeeree M, et al. Disseminated Cunninghamella bertholletiae infection with spinal epidural abscess in a kidney transplant patient: case report and literature review. Transpl Infect Dis. 2014;16:658–65.CrossRef
14.
go back to reference Rozich J, Holley HP Jr, Henderson F, et al. Cauda equina syndrome secondary to disseminated zygomycosis. JAMA. 1988;260:3638–40.CrossRef Rozich J, Holley HP Jr, Henderson F, et al. Cauda equina syndrome secondary to disseminated zygomycosis. JAMA. 1988;260:3638–40.CrossRef
15.
go back to reference Boody B, Jenkins T, Maslak J, et al. Vertebral osteomyelitis and spinal epidural abscess: an evidence-based review. J Spinal Disord Tech. 2015;28:E316-327.CrossRef Boody B, Jenkins T, Maslak J, et al. Vertebral osteomyelitis and spinal epidural abscess: an evidence-based review. J Spinal Disord Tech. 2015;28:E316-327.CrossRef
16.
go back to reference Wang Q, Liu B, Yan Y. Disseminated mucormycosis (DM) after pneumonectomy: a case report. BMC Infect Dis. 2016;16:337.CrossRef Wang Q, Liu B, Yan Y. Disseminated mucormycosis (DM) after pneumonectomy: a case report. BMC Infect Dis. 2016;16:337.CrossRef
17.
go back to reference Katragkou A, Walsh TJ, Roilides E. Why is mucormycosis more difficult to cure than more common mycoses? Clin Microbiol Infect. 2014;20:74–81.CrossRef Katragkou A, Walsh TJ, Roilides E. Why is mucormycosis more difficult to cure than more common mycoses? Clin Microbiol Infect. 2014;20:74–81.CrossRef
18.
go back to reference Baldin C, Ibrahim AS. Molecular mechanisms of mucormycosis—the bitter and the sweet. PLoS Pathog. 2017;13:e1006408.CrossRef Baldin C, Ibrahim AS. Molecular mechanisms of mucormycosis—the bitter and the sweet. PLoS Pathog. 2017;13:e1006408.CrossRef
19.
go back to reference von Pohle WR. Disseminated mucormycosis presenting with lower extremity weakness. Eur Respir J. 1996;9:1751–3.CrossRef von Pohle WR. Disseminated mucormycosis presenting with lower extremity weakness. Eur Respir J. 1996;9:1751–3.CrossRef
20.
Metadata
Title
Paraplegia secondary to disseminated mucormycosis: case report and literature review
Authors
Xiangjun Shi
Lei Qi
Boran Du
Xingchen Yao
Xinru Du
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07373-8

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue